CARDIOVASCULAR MANIFESTATIONS IN PATIENTS WITH THYROID DYSFUNCTION
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- To study the prevalence of cardiovascular manifestations in patients of thyroid dysfunction
研究概览
简要总结
Purpose of the trial :- To study various cardiovascular manifestations in patients with thyroid dysfunction.
Objectives:
PRIMARY OBJECTIVES:
• To study the prevalence of cardiovascular manifestations in patients of thyroid dysfunction
• To study the effect of treatment on the cardiovascular manifestations in these patients
SECONDARY OBJECTIVES:
• To study the effect of treatment on metabolic profile in patients with thyroid disorders
• To study the effect of treatment on NT Pro BNP levels in patients with thyroid disorders
Some major findings and references:
-
In a study conducted by M.Schultz et al, NT-pro-BNP levels were more than four times higher in hyperthyroid than hypothyroid patients, with mean values of 30 and 7 pmol/l, respectively ( P < 0·001). Serum NT-pro-BNP levels correlated to the thyroid function ( vs. free T4 estimate: r = 0·52, P < 0·0001, n = 57). Treatment resulted in significant increases in NT-pro- BNP in both hypothyroid groups, and decreases in both hyperthyroid groups.
-
Regarding hyperthyroidism, in one study conducted by Hailu Abera Mulatu, Echocardiographic abnormalities were detected in half (50.7%) of the patients. The study showed that (18.5%) patients had heart failure at initial presentation with the most common cardiovascular manifestations being exertional dyspnea (54.8%), pitting edema (18.5%) and elevated jugular venous pressure (15.8%). Nearly half (48.6%) of the patients had hypertension, and atrial fibrillation was seen in 11% of patients.(4.1%) patients had heart failure with reduced ejection fraction while another (4.1%) patients had isolated right sided heart failure. Pulmonary hypertension with pulmonary artery systolic pressure of 35 mmHg or more was found in (37%) patients.
-
Regarding hypothyroidism, in a study by Preshant Shrivastava, more than 65% subjects were found to have clinically significant cardiovascular changes. ECG changes observed were Sinus bradycardia in 35.5%, Low voltage complexes in 16.6%, T Wave inversion in 7.8%, RBBB in 4.4%, and QTc prolongation in 2.2% cases. About 64% cases had changes as observed in echocardiographic examination. Most common finding was Diastolic dysfunction seen in 20% cases. This was followed by Pericardial Effusion and Increased IVSD thickness in 16.6% cases each. Increased LVPW thickness was seen in 11.1% cases.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 99.00 Year(s)(—)
- 性别
- All
入选标准
- •Patients falling into the categories of hyperthyroidism, subclinical hypothyroidism and hypothyroidism.
排除标准
- •Known case of Diabetes Mellitus
- •Known case of Coronary Artery Disease, COPD (Previously diagnosed), Chronic Kidney Disease(Previously diagnosed), and Chronic Liver Disease(Previously diagnosed)
- •Pateints taking drugs which affect thyroid function 4.
结局指标
主要结局
To study the prevalence of cardiovascular manifestations in patients of thyroid dysfunction
时间窗: Less than or equal to One year
次要结局
- To study the effect of treatment on the metabolic profile in patients with thyroid disorders(Less than or equal to One year)
- To study the effect of treatment on NT ProBNP Levels in pateints with thyroid disorders(Less than or equal to One year)
